NCT00769496View on ClinicalTrials.gov

BAY 77-1931 Long-term Extension From Phase II Study

PHASE2CompletedINTERVENTIONAL

Enrollment

145

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

Hyperphosphatemia

Interventions

DRUG

BAY 77-1931

Lanthanum Carbonate (BAY 77-1931)

Trial Locations (14)

441-8023

Toyohashi

498-0006

Yatomi

261-0011

Chiba

277-0084

Kashiwa

286-0041

Narita

285-0846

Sakura

730-0811

Hiroshima

070-0030

Asahikawa

780-0066

Kochi

780-8040

Kochi

781-5103

Kochi

701-0202

Okayama

564-0053

Suita

770-0011

Tokushima

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY